Recommended Resources
- Body Mass Index Calculator
- Broken Link Checker
- Browser Shots
- Cancer Specialist
- HGH
- HGH Injections
- Hormone Decline Graphs / Calculator
- Hormone Therapy
- Human Growth Hormone
- Medical Dictionary Search
- Medical Drugs Search
- Medical Symptoms Search
- Quality of Life Assessment
- Ron Paul 2012
- Ron Paul TV
- Testosterone
- Testosterone Replacement Therapy
- Testosterone Therapy
- Weight Loss
Categories
- Anatomy
- Biochemistry
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Cardiology
- Cell Medicine
- Cell Therapy
- Chemistry
- DNA
- Embryology
- Future Medicine
- Gene Medicine
- Gene Therapy
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Human Genetics
- IVF Treatment
- Longevity Medicine
- Medical News
- Medical School
- Medical Technology
- Medicine
- Molecular Genetics
- Molecular Medicine
- Muscular Dystrophy Stem Cells
- Nano Medicine
- Nanotechnology
- Pet Stem Cell Therapy
- Stem Cell Therapy
Archives
Category Archives: Genetic Therapy
Shock Therapy: New Twist on an Old Treatment for Depression – Research Summary
BACKGROUND: Depression is a medical illness that involves the brain. Continue reading
Posted in Genetic Therapy
Tagged after-the-type, antidepressant, depression, interview-with, medical, medical-illness, often-portrayed, other-therapies, procedure, richard-weiner, therapies-, time, treatments-were, type-
Comments Off
Scientists Find Genetic Difference In Highly-Sensitive People
LOS ANGELES (CBS) Do people say you are highly sensitive whether it be physically or emotionally? While it can feel like a burden, it can also mean a greater capacity for work, love and compassion. I knew that I was more sensitive, that I took things deeper and harder, Ane Axford said Continue reading
Posted in Genetic Therapy
Tagged a-bit-more, a-large-portion, a-normal-degree, arons, arthur-aron, elaine-aron-, large-portion, more-activation, normal-degree, population, sandra-clifton-, scientists-say, secondary, the-population, the-secondary
Comments Off
Genetic test can accurately predict spread of eye cancer
Researchers at Washington University School of Medicine in St. Continue reading
Posted in Genetic Therapy
Tagged a-decade-ago-, a-dozen-genes, a-genetic-test, a-patient-has, a-simple-test, journal, medicine, ophthalmology, school, test, united, united-states, visual-sciences, william-harbour
Comments Off
Genetic Test Identifies Eye Cancer Tumors Likely to Spread
Newswise Researchers at Washington University School of Medicine in St. Louis have developed a genetic test that can accurately predict whether the most common form of eye cancer will spread to other parts of the body, particularly the liver. In 459 patients with ocular melanoma at 12 centers in the United States and Canada, the researchers found the test could successfully classify tumors more than 97 percent of the time. Continue reading
Posted in Genetic Therapy
Tagged a-decade-ago-, a-genetic-test, a-simple-test, beyond-the-eye, harbour, journal, medicine, ophthalmology, time, united, united-states, visual-sciences, william-harbour
Comments Off
Diagnosing a Rare, Genetic Disease
by Gary Emmett, M.D. Five years ago, a one-year-old boy named Connor was brought into my office for a second opinion. He had gone to a fine pediatrician on the Main Line who knew that something was very wrong, but did not know exactly what. Continue reading
Posted in Genetic Therapy
Tagged a-machine-and, a-patient-has, a-rare-genetic, a-single-gene, a-specific-gene, a-support-group, a-very-bright, connor, easter, media, office
Comments Off
Genetic predictor of breast cancer response to chemotherapy
Public release date: 10-May-2012 [ | E-mail | Share ] Contact: Dr. Hilary Glover hilary.glover@biomedcentral.com 44-020-319-22370 BioMed Central Chemotherapy is a major first line defense against breast cancer. Continue reading
Posted in Genetic Therapy
Tagged a-major-first, characteristics, dna, expression, from-the-tumor, hilary-glover, juravinski, media, media-contact, medical, press-officer, researchers, susceptibility, university
Comments Off
Vertex’s Cystic Fibrosis Therapy Is Called ‘Game-Changing’
Log in to manage your products and services from The New York Times and the International Herald Tribune. Don’t have an account yet? Create an account E-Mail or Member ID Password Remember Me Log In Continue reading
Posted in Genetic Therapy
Tagged account-yet, and-the, herald-tribune-, password, products, products-and, remember, tribune
Comments Off
Vertex: Two-Drug Cystic Fibrosis Therapy Improves Lung Function
Updated with stock price, analyst reaction. CAMBRIDGE, Mass. (TheStreet) — Vertex Pharmaceuticals(VRTX) released preliminary data Monday showing two drugs — the experimental VX-809 and currently marketed Kalydeco — significantly improved lung function in patients with the most common genetic mutation causing cystic fibrosis. Continue reading
Posted in Genetic Therapy
Tagged a-pivotal-phase, amount, article, european, f508del, function-, kalydeco, lung-function, phase, protein-on-the, study, summer, surface, sweat-chloride, writer
Comments Off
DiaGenic ASA: DiaGenic Reports Completion of Data Collection and Genetic Analyses in a Unique Study on Familial …
OSLO, Norway–(BUSINESS WIRE)– Regulatory News: DiaGenic ASA (OSE:DIAG.OL – News): DiaGenic today reports on the finalization of data collection and database lock of a blinded study in a Norwegian cohort of 80 patients with familial Parkinsons disease (PD). Continue reading
Posted in Genetic Therapy
Tagged a-good-position, brain, disease-should, european, gene-signature, genics-european, neurology, norway, norwegian, professor, study, unique, university, with-or-without
Comments Off
Not all tumor cells are equal: Stanford study reveals huge genetic diversity in cells shed by tumors
Public release date: 7-May-2012 [ | E-mail | Share ] Contact: Krista Conger kristac@stanford.edu 650-725-5371 Stanford University Medical Center STANFORD, Calif. The cells that slough off from a cancerous tumor into the bloodstream are a genetically diverse bunch, Stanford University School of Medicine researchers have found Continue reading
Posted in Genetic Therapy
Tagged a-growing-sense, a-quick-blood, bloodstream, expression, first, school, show-the-extent, slough-off-from, tumor
Comments Off
New Genetic Discoveries and Treatment for Hepatitis C [Viewpoint]
Michael Pacanowski, PharmD, MPH; Shashi Amur, PhD; Issam Zineh, PharmD, MPH Author Affiliations: Genomics Group, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Treatment of chronic hepatitis C (CHC) is a prototype for personalized medicine. Combination therapy with peginterferon alfa plus ribavirin was the standard of care for more than a decade Continue reading
Posted in Genetic Therapy
Tagged discovery, evolution, genomics-group, include-direct, research, silver, silver-spring, standard, strongest, such-as-viral, translational, triple-therapy, viewpoint, viral-genotype, with-interferon
Comments Off
Lewis speaks on gene therapy at Lexington Community Education event
In a recent talk sponsored by Lexington Community Education, author and genetics expert Ricki Lewis wrapped a lecture on human genetics and gene therapy in the genuinely moving stories of children whose lives were altered — some for good, some … Continue reading
Posted in Gene Therapy, Genetic Therapy, Genetics
Comments Off
Hot flashes more likely for certain smokers
THURSDAY, May 3 (HealthDay News) — Women smokers with certain gene variants are at increased risk for menopausal hot flashes compared to smokers without these genetic differences, a new study says. An analysis of data from nearly 300 late reproductive-age women who were followed for 11 years showed that smokers with specific variations (single nucleotide polymorphisms) in genes that affect metabolism are more likely to have hot flashes than smokers without these gene variants. Continue reading
Posted in Genetic Therapy
Tagged a-from-nearly, a-journal-news, environment, health, human-services, medicine-at-the, pennsylvania, perelman, public-health, samantha-butts, smokers-without, university, women
Comments Off
Life-saving enzyme eludes genetic disorder victim
Jharkhand Muslim Majlis Musawar, which had sponsored Sadaf's trip to Delhi, has sought a fresh appointment with the Ranchi MP to press for Sadaf's free treatment. Continue reading
Posted in Genetic Therapy
Tagged delhi-, free-treatment-, fresh-appointment, has-sought, jharkhand-muslim, majlis-musawar, musawar, muslim, press-for, ranchi, sadaf, which-had, with-the, with-the-ranchi
Comments Off
Researchers Discover First Gene Linked to Missing Spleen in Newborns
New Discovery of a Genetic Mutation in Congenital Asplenia May Lead to Genetic Prenatal Screening in Patients with the Rare, But Deadly, Disorder Newswise NEW YORK (May 3, 2012) — Researchers at Weill Cornell Medical College and Rockefeller University have identified the first gene to be linked to a rare condition in which babies are born without a spleen, putting those children at risk of dying from infections they cannot defend themselves against. Continue reading
Posted in Genetic Therapy
Tagged a-usually-lack, alexandre-bolze, condition, developing, disorder, human-genetics, laboratory, mouse, nkx2-5, organ, research, spleen, weill-cornell
Comments Off
Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
NOVATO, Calif., May 1, 2012 /PRNewswire/ –Ultragenyx Pharmaceutical Inc., a biotechnology company focused on developing treatments for rare and ultra-rare genetic disorders, today announced results from a first-in-human, multi-center, Phase 1 study of UX001 in patients with hereditary inclusion body myopathy (HIBM) showing that UX001 was well-tolerated with an expected extended release profile on absorption after oral administration. UX001 is an extended release formulation of sialic acid intended as a substrate replacement therapy for HIBM, a severe, neuromuscular disease caused by sialic acid deficiency Continue reading
Posted in Genetic Therapy
Tagged a-12-16-hour, a-treatment-for, australia-, chief-executive, focuses-on-rare, hibm, pattern-or-dose, potential, safety, sialic-acid, society, ultragenyx, which-the-unmet, year
Comments Off
FDA approves new orphan drug to treat a form of Gaucher disease
FDA NEWS RELEASE For Immediate Release: May 1, 2012 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves new orphan drug to treat a form of Gaucher disease The U.S. Food and Drug Administration today approved Elelyso (taliglucerase alfa) for long-term enzyme replacement therapy to treat a form of Gaucher disease, a rare genetic disorder. Gaucher disease occurs in people who do not produce enough of an enzyme called glucocerebrosidase. Continue reading
Posted in Genetic Therapy
Tagged consumer, disease, disease-include, efficacy, initial-therapy, liver-or-spleen, media, media-inquiries, office, patients-with, platelet-counts, reducing-spleen, united
Comments Off
Elelyso Approved for Gaucher Disease
TUESDAY, May 1 (HealthDay News) — Elelyso (taliglucerase alfa) has been approved by the U.S. Food and Drug Administration as a long-term enzyme replacement therapy for people with a rare genetic disorder called type 1 Gaucher disease. Continue reading
Posted in Genetic Therapy
Tagged a-long-term-enzyme, a-rare-genetic, disease, disorder-called, elelyso, gaucher, has-been, long-term-enzyme, people-with, rare-genetic, therapy-for
Comments Off